Careers  |  Sign In  |  Register  |   Twitter

Latest in Rheumatology

Reuters Health • The Doctor's Channel Daily Newscast

TNF inhibitors overall not linked to serious infections

NEW YORK (Reuters Health) – Contrary to persistent concerns, the use of tumor necrosis factor (TNF)-alpha antagonists, as a group, to treat autoimmune diseases is not associated with an increased risk of hospitalization for infection in the year after starting treatment, according to a report in the...

Reuters Health • The Doctor's Channel Daily Newscast

Multiple factors complicate hip and knee replacement

NEW YORK (Reuters Health) – Smoking, COPD and peptic ulcer disease are important risk factors for complications in patients undergoing elective primary total hip replacement (THR) or primary total knee replacement (TKR), researchers report in 2 on-line papers published July 11th and 18th in Arthritis...

Reuters Health • The Doctor's Channel Daily Newscast

Pegloticase improves uric acid, symptoms in some with treatment-resistant gout

NEW YORK (Reuters Health) – Biweekly injections of pegloticase may quickly lower uric acid and ease symptoms in some gout patients who don’t get better with usual treatment, according to a new study. The research was funded by the pharmaceutical company Savient, which markets the drug as Krystexxa....